FDA Steps Up Focus On Computational Modeling For Devices With Draft Guidance
The draft guidance outlines information on computational and simulation modeling studies that should be included in FDA device submissions. FDA has been encouraging companies to focus on modeling studies with a goal that they could eventually replace costly bench and animal studies.
You may also be interested in...
FDA is moving ahead with development of a digital library for computer modeling and simulation tools for device development as well as an international standard for the verification and validation of such models. It recently hosted a stakeholder workshop to gain more feedback on the project.
The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.